{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:06:08Z","timestamp":1761743168018},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11934-008-0077-1","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T10:49:31Z","timestamp":1227696571000},"page":"445-451","source":"Crossref","is-referenced-by-count":21,"title":["Botulinum toxin treatment for overactive bladder: Risk of urinary retention"],"prefix":"10.1007","volume":"9","author":[{"given":"Ahmed M.","family":"Shaban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"77_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P. Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, et al.: The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002, 21:167\u2013178.","journal-title":"Neurourol Urodyn"},{"key":"77_CR2","first-page":"24","volume":"71","author":"D.D. Dykstra","year":"1990","unstructured":"Dykstra DD, Sidi AA: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehab 1990, 71:24\u201326.","journal-title":"Arch Phys Med Rehab"},{"key":"77_CR3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B. Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, et al.: Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000, 164:692\u2013697.","journal-title":"J Urol"},{"key":"77_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","volume":"180","author":"L. Brubaker","year":"2008","unstructured":"Brubaker L, Richter HE, Visco A, et al.: Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 2008, 180:217\u2013222.","journal-title":"J Urol"},{"key":"77_CR5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","volume":"66","author":"H. Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T, et al.: Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 2005, 66:82\u201387.","journal-title":"Urology"},{"key":"77_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","volume":"65","author":"C.P. Smith","year":"2005","unstructured":"Smith CP, Nishiguchi J, O\u2019Leary M, et al.: Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005, 65:37\u201341.","journal-title":"Urology"},{"key":"77_CR7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","volume":"45","author":"M. Khera","year":"2004","unstructured":"Khera M, Somogyi GT, Kiss S, et al.: Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 2004, 45:987\u2013993.","journal-title":"Neurochem Int"},{"key":"77_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","volume":"66","author":"M. Khera","year":"2005","unstructured":"Khera M, Somogyi GT, Salas NA, et al.: In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology 2005, 66:208\u2013212.","journal-title":"Urology"},{"key":"77_CR9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","volume":"100","author":"P. Abrams","year":"2007","unstructured":"Abrams P, Andersson KE: Muscarinic receptor antagonists for overactive bladder. BJU Int 2007, 100:987\u20131006.","journal-title":"BJU Int"},{"key":"77_CR10","unstructured":"National Institute for Health and Clinical Excellence. NICE clinical guideline 40. Available at http:\/\/www.nice.org.uk\/guidance\/index.jsp?action=download&o=30282 . Accessed July 3, 2008."},{"key":"77_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","volume":"44","author":"T. Leippold","year":"2003","unstructured":"Leippold T, Reitz A, Schurch B: Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003, 44:165\u2013174.","journal-title":"Eur Urol"},{"key":"77_CR12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2003.04714.x","volume":"93","author":"M. Harper","year":"2004","unstructured":"Harper M, Fowler CJ, Dasgupta P: Botulinum toxin and its applications in the lower urinary tract. BJU Int 2004, 93:702\u2013706.","journal-title":"BJU Int"},{"key":"77_CR13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","volume":"174","author":"M. Ghei","year":"2005","unstructured":"Ghei M, Maraj BH, Miller R, et al.: Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 2005, 174:1873\u20131877; discussion 7.","journal-title":"J Urol"},{"key":"77_CR14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","volume":"171","author":"A. Reitz","year":"2004","unstructured":"Reitz A, Schurch B: Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 2004, 171:804; discussion 805.","journal-title":"J Urol"},{"key":"77_CR15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R. Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V, et al.: A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 2005, 174:984\u2013989.","journal-title":"J Urol"},{"key":"77_CR16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","volume":"62","author":"V. Kalsi","year":"2007","unstructured":"Kalsi V, Gonzales G, Popat R, et al.: Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 2007, 62:452\u2013457.","journal-title":"Ann Neurol"},{"key":"77_CR17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.urology.2006.05.054","volume":"68","author":"H.C. Kuo","year":"2006","unstructured":"Kuo HC: Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? Urology 2006, 68:993\u2013997; discussion 997\u2013998.","journal-title":"Urology"},{"key":"77_CR18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","volume":"178","author":"H.C. Kuo","year":"2007","unstructured":"Kuo HC: Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 2007, 178:1359\u20131363.","journal-title":"J Urol"},{"key":"77_CR19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","volume":"48","author":"H. Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T, et al.: Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 2005, 48:984\u2013990; discussion 990.","journal-title":"Eur Urol"},{"key":"77_CR20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J. Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Stohrer M: Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005, 47:653\u2013659.","journal-title":"Eur Urol"},{"issue":"Suppl1","key":"77_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-5347(08)61293-8","volume":"179","author":"C. Dowson","year":"2008","unstructured":"Dowson, C, Sahai A, Roux J, et al.: Efficacy of repeated injections of Botulinum toxin-A in patients with overactive bladder and idiopathic detrusor overactivity. J Urol 2008, 179(Suppl 1):441.","journal-title":"J Urol"},{"key":"77_CR22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","volume":"63","author":"H.C. Kuo","year":"2004","unstructured":"Kuo HC: Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 2004, 63:868\u2013872.","journal-title":"Urology"},{"key":"77_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"D.M. Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M, et al.: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 2006, 176:177\u2013185.","journal-title":"J Urol"},{"key":"77_CR24","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"A. Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P: Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 2007, 177:2231\u20132236.","journal-title":"J Urol"},{"key":"77_CR25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A. Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G, et al.: European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004, 45:510\u2013515.","journal-title":"Eur Urol"},{"key":"77_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","volume":"63","author":"D.E. Rapp","year":"2004","unstructured":"Rapp DE, Lucioni A, Katz EE, et al.: Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004, 63:1071\u20131075.","journal-title":"Urology"},{"key":"77_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","volume":"54","author":"V. Kalsi","year":"2008","unstructured":"Kalsi V, Apostolidis A, Gonzales G, et al.: Early effect on the overactive bladder symptoms following Botulinum neurotoxin type A injections for detrusor overactivity. Eur Urol 2008, 54:181\u2013187.","journal-title":"Eur Urol"},{"key":"77_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","volume":"3","author":"T.M. Kessler","year":"2005","unstructured":"Kessler TM, Danuser H, Schumacher M, et al.: Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 2005, 3:231\u2013236.","journal-title":"Neurourol Urodyn"},{"key":"77_CR29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1569-9056(02)80519-X","volume":"1","author":"P. Radziszewski","year":"2002","unstructured":"Radziszewski P, Borkowski A: Botulinum toxin type A intravesical injections for intractable bladder overactivity. Eur Urol Suppl 2002, 1:134.","journal-title":"Eur Urol Suppl"},{"key":"77_CR30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1569-9056(05)80652-9","volume":"4","author":"A. Ruffion","year":"2005","unstructured":"Ruffion A, Tanneau Y, Gignoux AJ, et al.: What is the optimal dose of Botulinum toxin A Dysport in neurogenic detrusor overactivity? A dose-effect study. Euro Urol Suppl 2005, 4:164.","journal-title":"Euro Urol Suppl"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-008-0077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-008-0077-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-008-0077-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:52:06Z","timestamp":1559422326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-008-0077-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s11934-008-0077-1","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}